Cited by 185Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

Brd2 disruption in mice causes severe obesity without Type 2 diabetes

Open access
Wang, Fangnian, Liu, Hongsheng, Blanton, Wanda P., Belkina, Anna, Lebrasseur, Nathan K., Denis, Gerald V.·2010·Biochemical Journal

Abstract

Certain human subpopulations are metabolically healthy but obese, or metabolically obese but normal weight; such mutations uncouple obesity from glucose intolerance, revealing pathways implicated in Type 2 diabetes. Current searches for relevant genes consume significant effort. We have reported previously a novel double bromodomain protein called Brd2, which is a transcriptional co-activator/co-repressor with SWI/SNF (switch mating type/sucrose non-fermenting)-like functions that regulates chromatin. In the present study, we show that wholebody disruption of Brd2, an unusual MHC gene, causes lifelong severe obesity in mice with pancreatic islet expansion, hyperinsulinaemia, hepatosteatosis and elevated pro-inflammatory cytokines, but, surprisingly, enhanced glucose tolerance, elevated adiponectin, increased weight of brown adipose tissue, heat production and expression of mitochondrial uncoupling proteins in brown adipose tissue, reduced macrophage infiltration in white adipose tissue, and lowered blood glucose, leading to an improved metabolic profile and avoiding eventual Type 2 diabetes. Brd2 is highly expressed in pancreatic β-cells, where it normally inhibits β-cell mitosis and insulin transcription. In 3T3-L1 pre-adipocytes, Brd2 normally co-represses PPAR-γ (peroxisome-proliferator-activated receptor-γ) and inhibits adipogenesis. Brd2 knockdown protects 3T3-L1 adipocytes from TNF-α (tumour necrosis factor-α)-induced insulin resistance, thereby decoupling inflammation from insulin resistance. Thus hypomorphic Brd2 shifts energy balance toward storage without causing glucose intolerance and may provide a novel model for obese metabolically healthy humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20090928

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, F., Liu, H., Blanton, W. P., Belkina, A., Lebrasseur, N. K., & Denis, G. V.
Affiliations
Boston University (US)
Corresponding author
  • Wang, Fangnian
  • Liu, Hongsheng
  • Belkina, Anna
Venue
Biochemical Journal
Published
2009-12-14
Volume
425
Issue
1
Pages
71-85
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2150727212
Cited by
185
References
59
Citations by year
2026: 4 · 2025: 4 · 2024: 11 · 2023: 4 · 2022: 13 · 2021: 14 · 2020: 13 · 2019: 9 · 2018: 8 · 2017: 18 · 2016: 18 · 2015: 16 · 2014: 14 · 2013: 12 · 2012: 12
FWCI
6.07
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R29CA075107)
  • National Institute of Allergy and Infectious Diseases (T32AI007309)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK046200, R01DK056690)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
BRD2, bromodomain proteins, obesity, type 2 diabetes, metabolically healthy obesity, pancreatic beta cells, brown adipose tissue, mitochondrial uncoupling, insulin resistance, adipogenesis, PPARγ, inflammation, adiponectin, hepatic steatosis, corepressors, 3T3-L1 adipocytes, TNF-α
MeSH terms
Bromodomain Containing Proteins, Animals, Blood Glucose, Cell Differentiation, Cell Line, Chromosomal Proteins, Non-Histone, Diabetes Mellitus, Type 2, Fasting, Humans, Insulin, Insulin Resistance, Macrophages, Mice, Inbred C57BL, Obesity, Severity of Illness Index, Transcription Factors, Gene Expression, Cytokines, Protein Serine-Threonine Kinases, Adipocytes, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Leptin, 3T3-L1 Cells, Cell Line, Tumor, PPAR gamma, Mice, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review